Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Psoriatic Arthritis: Pooled Results from the Secukinumab Phase 3 Trial Program

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image